StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 08/19/2013 -- StockRunway.com issues special report on - Affymax, Inc.(OTCMKTS:AFFY), Buffalo Wild Wings(NASDAQ:BWLD), CODESMART HOLDINGS(OTCBB:ITEN), Invivo Therapeutics Holdings Corp(OTCBB:NVIV)
Affymax, Inc.(OTCMKTS:AFFY) stock is at $1.58. The stock opened the session at $1.582 and touched its highest price point at $1.59.
Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained positive with +18.8% during previous three months trade. Its recent trading volume was 350.12k shares in comparison to its usual trading volume of 1.14 million shares. Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses. It offers OMONTYS (peginesatide) injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic peptide-based erythropoiesis stimulating agent designed to stimulate production of red blood cells. The company has a strategic collaboration with Takeda Pharmaceutical Company Limited to develop and commercialize OMONTYS; and a license, manufacturing, and supply agreement with Nektar Therapeutics AL Corporation to manufacture, develop, and commercialize OMONTYS. Affymax, Inc. was founded in 2001 and is headquartered in Palo Alto, California.
Is AFFY a Solid Investment at These Levels? Read This Report For Details
Buffalo Wild Wings(NASDAQ:BWLD) stock is at $104.92, down -0.14 percent from its previous close of $0.385. Its today’s volume is 1.45 million shares in comparison to its usual trading volume of 410,702.00 shares. The stock opened the session at $104.59 and touched its highest price point at $106.50.
BWLD’s quarterly performance remained green with the percentage of +10.42, while its year to date performance showed that the stock advanced overall +44.08%. Buffalo Wild Wings, Inc. engages in the ownership, operation, and franchise of restaurants primarily in the United States. It offers chicken and various food and beverage items, as well as serves bottled beers, wines, and liquor. As of July 30, 2013, the company owned and operated, and franchised approximately 930 Buffalo Wild Wings Grill & Bar restaurants in the United States and Canada. Buffalo Wild Wings, Inc. was founded in 1982 and is headquartered in Minneapolis, Minnesota.
Has BWLD Found The Bottom and Ready To Move Up? Find Out Here
CODESMART HOLDINGS(OTCBB:ITEN) experienced a plunge of -11.32% to a market valuation of $35.96M per share for previous trading session. After opening the day at $2.81 per share, volume surged to 144,877.00 .
During last one month it slipped with the percentage of -64.77. Its year to date performance remained adverse with -48.69%. CodeSmart Holdings, Inc. focuses on providing on-line education services for medical coding and billing to healthcare professionals in the United States.
Has ITEN Found The Bottom And Ready To Gain Momentum? Find Out Here
Invivo Therapeutics Holdings Corp(OTCBB:NVIV) opened its shares at the price of $4.15 for the day, its closing price was $4.20 after gaining +0.43% for the day. The company traded with the total volume of 158,762.00 shares while its average trading aptitude remained 561,786.00 shares. The company has total of 78.58 million outstanding shares and its total market capitalization is $329.87 million. Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions. It intends to develop and commercialize biocompatible polymer scaffolding devices to treat acute spinal cord injuries; biocompatible hydrogel for use as dural sealants, dural replacements, and nerve conduits, as well as for local controlled release of methylprednisolone to treat spinal cord injuries and peripheral nerve injuries; and biocompatible polymer scaffolding devices seeded with autologous human neural stem cells to treat acute and chronic spinal cord injuries. The company was founded in 2005 and is headquartered in Cambridge, Massachusetts.
For How Long NVIV’s Gloss will Attract Investors? Find out via this report
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at http://www.stockrunway.com/disclaimer/" rel="nofollow" href="http://www.stockrunway.com/disclaimer/">: http://www.stockrunway.com/disclaimer/>
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)